PACB 毛利润历史(2016–2025)
Pacific Biosciences of California, Inc. (PACB) 年度毛利润历史(来自 SEC 财报)—— 每个财年的申报值。
$45.8MFY2025 · FY2016 以来:$44.2M → $45.8M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $45.8M | +22.8% |
| FY2024 | $37.3M | -29.4% |
| FY2023 | $52.8M | +7.6% |
| FY2022 | $49.0M | -16.7% |
| FY2021 | $58.9M | +80.7% |
| FY2020 | $32.6M | -5.8% |
| FY2019 | $34.6M | +37.8% |
| FY2018 | $25.1M | -27.6% |
| FY2017 | $34.7M | -21.5% |
| FY2016 | $44.2M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议